Sponsor pipeline

Abu Dhabi Health Services Company clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 1/2

Not charted: 4 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 1/2
NCT06836206	The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in…	End Stage Renal Disease (ESRD)	Recruiting	2025-02-20
Not applicable
NCT06535542	Integrating Whole Genome Sequencing and Digital Twins Into the Management of…	Hypercholesterolemia, Autosomal Dominant	Recruiting	2025-03-25
Not specified
NCT06535503	Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu…	ST Elevation Myocardial Infarction	Recruiting	2025-02-17
NCT07015255	Assessing the Burden of Respiratory Syncytial Virus (RSV)	Respiratory Syncytial Virus (RSV) Infection	Not Yet Recruiting	2025-06-19
NCT06694961	Knowledge of Adolescent Well-care Visits and Attitudes Amongst Physicians	Adolescent Health	Enrolling by Invitation	2024-11-19

Get alerts when Abu Dhabi Health Services Company's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.